A Study of HR19024 in Subjects With Advanced Solid Tumor
Clinical trial NCT05463432 · COMPLETED
Trial details
- NCT number
- NCT05463432
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2024-10-22
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.